- Jan 29, 2018

Study suggests PD-1 inhibitors against aggressive pediatric brain cancer subtype

A University of Colorado Cancer Center study published in the journal Pediatric Blood Cancers lays the scientific groundwork for the use of PD-1 inhibitors with an aggressive form of brain cancer, namely supratentorial pediatric ependymoma.

Developing ‘kinder’ treatments for a devastating childhood cancer

Breakthrough as new drug promises to shield child cancer patients from hearing loss

Study finds higher breast cancer risk after certain forms of childhood cancer treatment

Aggressive Cancer Cells Transformed Into Healthy Cells in Breakthrough

Cardiac RT May Amplify Late Disease Risk in Pediatric Cancer Survivors

Are Cannabis-Based Medicines Safe for Children With Cancer?

Homoharringtonine May be ‘Better Alternative’ to Etoposide In Pediatric AML

Researchers discover new therapeutic approach for neuroblastoma

Solving the Mystery of Long-Lasting Cancer Treatment – Scientists Reveal New Insights

The challenge of treating childhood brain cancers

Recent Posts

Study suggests PD-1 inhibitors against aggressive pediatric brain cancer subtype

Archive

Search By Tags